Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study.
about
Vitamin E for Alzheimer's dementia and mild cognitive impairmentN-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunitiesCobalamin deficiency, hyperhomocysteinemia, and dementiaSystematic review of safety and tolerability of a complex micronutrient formula used in mental healthDatabase analysis of children and adolescents with bipolar disorder consuming a micronutrient formula.Broad-spectrum micronutrient formulas for the treatment of psychiatric symptoms: a systematic review.The effect of S-adenosylmethionine on cognitive performance in mice: an animal model meta-analysis.Vitamin E for Alzheimer's dementia and mild cognitive impairment.Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy.Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics StrategiesDietary Factors and Cognitive DeclineDietary deficiency increases presenilin expression, gamma-secretase activity, and Abeta levels: potentiation by ApoE genotype and alleviation by S-adenosyl methionine.Elevation of glutathione as a therapeutic strategy in Alzheimer disease.Use of vitamin and mineral supplements in long-term care home residents.New and emerging treatments for Alzheimer's disease.Positive argument for debate in J Neural Transmission: Alzheimer's disease: are we intervening too late? Yes, by years if not decades.Efficacy and cost of micronutrient treatment of childhood psychosis.Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.Implication of the nutritional and nonnutritional factors in the context of preservation of cognitive performance in patients with dementia/depression and Alzheimer disease.Latest treatment options for Alzheimer's disease, Parkinson's disease dementia and dementia with Lewy bodies.Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders.Prospects for the development of epigenetic drugs for CNS conditions.S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research.Emerging amyloid and tau targeting treatments for Alzheimer's disease.Emerging treatments for Alzheimer's disease for non-amyloid and non-tau targets.The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial.Redox Potential-Sensitive N-Acetyl Cysteine-Prodrug Nanoparticles Inhibit the Activation of Microglia and Improve Neuronal Survival.While I Still Remember: 30 Years of Alzheimer's Disease Research.Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.Apple juice improved behavioral but not cognitive symptoms in moderate-to-late stage Alzheimer's disease in an open-label pilot study.Vitamin E for Alzheimer's dementia and mild cognitive impairment
P2860
Q24202844-6F41EEB1-3011-4C63-9D7F-C4309CE2520BQ24568289-52AAC998-272F-45F3-B4C7-A3C0D2374A00Q24609123-4057424C-8FF2-4F16-B7F1-E74DC8F325D9Q33875871-39C79255-DFC9-461A-81C3-2C6B7F5FCCC7Q34199313-D27DADEA-8F57-48A1-B055-CCDB626B3DF5Q34318546-C1A3E54C-5C72-4788-AF59-398B676E59A2Q34408065-C652E255-311D-403C-8D3A-A855EBFB4F64Q34550138-801E2BFA-27D7-4729-AB84-280E7D0C8694Q35193956-AAF74B3D-BA13-4888-AE60-A26EAB46D8D0Q35752353-07766D6A-BC7F-455D-BB3E-5C357E5F19ACQ36593158-23F473A4-B3BA-4AC2-9F49-469E9E68C467Q37398555-94770948-DE08-4BD2-BB7D-8D54D17C0669Q37947939-59953492-D080-4DEE-9EC1-B8C219EF97B6Q37974976-CA408B75-E18A-4ED9-A6CE-F47EDF9277F8Q38006979-9C59CAB5-34D2-4465-8575-DE85A96E312AQ38025346-92193487-9257-495C-928C-B760AA880D74Q38059199-D8497A1C-AA74-4284-AEB7-ECF98BF24EFBQ38082670-B2420BD0-3F11-4185-B2B0-20B1E7475225Q38148458-EDC25FD8-87CE-459A-8EF6-F19DE6B76093Q38225930-C286212D-10AC-4228-BE3A-2168FA6BC2D9Q38229311-39CA5B5B-D860-4E9E-AE03-74F0B2E05CE3Q38497844-DDBB3B96-394B-4969-8614-3EF647D3CED1Q38691239-FC69CE1A-4FA7-45CB-B518-C9CD596AE455Q39296311-43E6A58F-D376-498B-BA88-3085AFC14130Q39296351-838F4F10-2535-40D8-BB18-335A6612C7BEQ42371638-5F253E63-9AE2-4F94-91EC-52637E1B6061Q46398250-AD5260BF-FCF3-4C22-ADBD-A4ED25445B6BQ47563110-27441804-A44A-41A0-8FA7-B553CA936406Q50663391-E55DF740-ED40-45A5-9823-345DD8427085Q53308769-E06FCC36-CCA7-4507-B0DB-3F7B703B54E7Q56092262-C3001791-E4D8-4149-BA78-AA48F6FDB5DF
P2860
Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Efficacy of a vitamin/nutriceu ...... lacebo-controlled pilot study.
@en
Efficacy of a vitamin/nutriceu ...... lacebo-controlled pilot study.
@nl
type
label
Efficacy of a vitamin/nutriceu ...... lacebo-controlled pilot study.
@en
Efficacy of a vitamin/nutriceu ...... lacebo-controlled pilot study.
@nl
prefLabel
Efficacy of a vitamin/nutriceu ...... lacebo-controlled pilot study.
@en
Efficacy of a vitamin/nutriceu ...... lacebo-controlled pilot study.
@nl
P2093
P2860
P356
P1476
Efficacy of a vitamin/nutriceu ...... lacebo-controlled pilot study.
@en
P2093
James Paskavitz
Ruth Remington
Thomas B Shea
P2860
P356
10.1177/1533317508325094
P407
P577
2008-12-03T00:00:00Z